These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7913179)

  • 1. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus.
    Bingley PJ; Bonifacio E; Gale EA
    Lancet; 1994 Jul; 344(8917):266-7. PubMed ID: 7913179
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined antibody screening for improved prediction of IDDM--modern strategies.
    Roll U; Ziegler AG
    Exp Clin Endocrinol Diabetes; 1997; 105(1):1-14. PubMed ID: 9088889
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytoplasmic islet cell antibodies and GAD antibodies in diagnosis of diabetes].
    Bieg S; Seissler J; Scherbaum WA
    Med Klin (Munich); 1995 Oct; 90(10):594-8. PubMed ID: 7500923
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibodies to glutamic acid decarboxylase (GADA) as markers of risk for development of insulin-dependent diabetes mellitus].
    Kretowski A; Szelachowska M; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 1998; 55(6):315-9. PubMed ID: 9857706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet autoantibodies and their use in predicting insulin-dependent diabetes.
    Bonifacio E; Bingley PJ
    Acta Diabetol; 1997 Oct; 34(3):185-93. PubMed ID: 9401639
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevalence and predictive value of islet cell autoantibodies and anti-glutamic acid decarboxylase in a family study in Lyons].
    Thivolet C
    Journ Annu Diabetol Hotel Dieu; 1992; ():165-71. PubMed ID: 1495236
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus.
    Orrell RW; Lane RJ; Maitland J; Leslie RD
    Lancet; 1994 Jul; 344(8917):267. PubMed ID: 7913180
    [No Abstract]   [Full Text] [Related]  

  • 8. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Auto-antibodies against glutamic acid decarboxylase and diabetes].
    Mandrup-Poulsen TR
    Ugeskr Laeger; 2007 Jan; 169(4):300-4. PubMed ID: 17274923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three cases of GAD65 antibody-positive diabetes with ketosis and abrupt onset resulting in non-insulin-dependent state.
    Morimoto J; Maruyama T; Kasuga A; Ozawa Y; Kobayashi A; Funakoshi S; Iwasaki R; Suzuki Y; Shimada A; Saruta T
    Diabetes Care; 1998 Nov; 21(11):2037-9. PubMed ID: 9802771
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 diabetes islet autoantibody markers.
    Winter WE; Harris N; Schatz D
    Diabetes Technol Ther; 2002; 4(6):817-39. PubMed ID: 12614488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate decarboxylase: an autoantigen in IDDM.
    Clare-Salzler MJ; Tobin AJ; Kaufman DL
    Diabetes Care; 1992 Jan; 15(1):132-5. PubMed ID: 1737532
    [No Abstract]   [Full Text] [Related]  

  • 16. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.
    Orban T; Sosenko JM; Cuthbertson D; Krischer JP; Skyler JS; Jackson R; Yu L; Palmer JP; Schatz D; Eisenbarth G;
    Diabetes Care; 2009 Dec; 32(12):2269-74. PubMed ID: 19741189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoantibodies in type 1 diabetes mellitus].
    Ziegler M; Ziegler B
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261
    [No Abstract]   [Full Text] [Related]  

  • 18. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
    [No Abstract]   [Full Text] [Related]  

  • 19. Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus.
    Petersen JS; Kyvik KO; Bingley PJ; Gale EA; Green A; Dyrberg T; Beck-Nielsen H
    BMJ; 1997 May; 314(7094):1575-9. PubMed ID: 9169400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay.
    Yu L
    Methods Mol Biol; 2016; 1433():85-91. PubMed ID: 26659802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.